Abstract:Background Although surgical resection or amputation has been the mainstay of localized chondrosarcoma management for many decades, its efficacy in patients with metastatic chondrosarcoma remains unknown, and likewise we do not know whether there are any tumor-or patient-related factors associated with better survival after surgery for metastatic chondrosarcoma. Questions/purposes (1) Is resection of the primary tumor associated with improved survival in patients with metastatic chondrosarcoma? (2) Which subgroups of patients with chondrosarcoma benefit more from resection in terms of survival? Methods We identified 200 of 222 patients with metastatic chondrosarcoma in the Surveillance, Epidemiology, and End Results (SEER) database between 1988 and 2014 based on the exclusion criteria. Among those patients, 107 (53.5%) underwent primary tumor resection or amputation. Patient information, including demographics (patient age, gender, race, year of diagnosis), tumor characteristics (primary site, histologic subtype, tumor grade, tumor size), and treatment (record of operation and radiation), was collected and included in the study. Kaplan-Meier analyses, log-rank tests, competing risks framework, multivariable Cox regression modeling, and interaction tests were conducted to assess the association of primary tumor resection and survival in the overall cohort and subgroups. Results Resection of the primary tumor was associated with improved overall survival (hazard ratio [HR], 0.481; 95% confidence interval [CI], 0.340-0.680; p < 0.001) and cancer-specific survival (HR, 0.493; 95% CI, 0.343-0.709; p < 0.001) after controlling for confounding variables. After controlling further for age, histologic subtype, and grade, primary tumor resection was associated with a survival advantage in patients with conventional subtype and Grade II chondrosarcoma (conventional subtype: HR, 0.403; 95% CI, 0.260-0.623 for overall survival and HR, 0.396; 95% CI, 0.250-0.627 for cancer-specific survival). However, primary tumor resection was not associated with increased survival in patients with metastatic chondrosarcoma who had the dedifferentiated subtype and Grade III malignancy. Conclusions The present study demonstrates a possible favorable association between primary tumor resection and survival in some patients with metastatic chondrosarcoma at initial diagnosis. Specifically, patients with conventional subtypes and Grade II malignancies who underwent primary tumor resection had better survival compared with those patients who did not have primary tumor resection. Thus, there might be a benefit from primary tumor resection in these patients, but given the limitations of this database, further prospective studies or randomized trials are needed to confirm our findings. In the meantime, this information might be helpful to consider when discussing surgical options with patients who have conventional, Grade 2 metastatic chondrosarcoma at diagnosis. Level of Evidence Level III, therapeutic study.

Primary cardiac sarcoma: demographics, genomic study correlation, and survival benefits of surgery with adjuvant therapy in U.S. population

Survival outcomes in patients with primary cardiac sarcoma in the United States

Does Resection of the Primary Tumor Improve Survival in Patients With Metastatic Chondrosarcoma?

Prognostic Analysis for Survival after Resections of Localized Primary Cardiac Sarcomas: A Single-Institution Experience

Primary cardiac synovial sarcoma: a clinicopathological, immunohistochemical, and molecular genetics study of five clinical cases

Clinicopathologic features and outcomes of primary cardiac tumors: a 16-year-experience with 212 patients at a Chinese medical center

Cardiac Morbidity and Mortality in Patients with Sarcoma: A Population-Based Study

Surgical and multitreatment approach in a case of primary cardiac angiosarcoma: A case report

Comprehensive genomic analysis of primary bone sarcomas reveals different genetic patterns compared with soft tissue sarcomas

Case report: Characteristics and nature of primary cardiac synovial sarcoma

Case Report: Successful Surgical Management of a Challenging Primary Cardiac Angiosarcoma

Rare Cardiac Tumor: Do We Know All About Cardiac Myxofibrosarcoma?

The Diagnosis and Treatment for Primary Cardiac Angiosarcoma with N-ras Gene Mutation and MSI-L: A Case Report and Review of the Literature

Successful multidisciplinary clinical approach and molecular characterization by whole transcriptome sequencing of a cardiac myxofibrosarcoma: A case report

Treatment of malignant primary cardiac tumors requires attention to cardiovascular complications: a single-center, retrospective study

Primary thoracic synovial sarcomas: clinical profile and treatment outcomes of a rare entity managed at a tertiary care centre

Isolated primary cardiac angiosarcoma

Primary sarcoma of prostate: A genomic landscape study.

Epidemiology, tumor characteristics and survival in patients with angiosarcoma in the United States: a population-based study of 4537 cases

Surgical Treatment of Primary Cardiac Tumors in Children: Experience of A Single Institute

Abstract 3421: Comparison of Mutations in Different Subtypes of Sarcomas and Its Clinical Implications